BioCentury
ARTICLE | Emerging Company Profile

Microbiome gets skinny

How Xycrobe is harnessing the skin microbiome to deliver dermal therapies

October 27, 2016 7:00 AM UTC

While other microbiome companies battle intestinal diseases with cocktails of gut bacteria or bacteria-derived compounds, Xycrobe Therapeutics Inc. is moving beyond the gut with a platform that harnesses commensal bacteria in skin for continuous, local delivery of therapies for acne, psoriasis and other dermal diseases.

Xycrobe’s platform engineers bacteria to produce therapeutic compounds, using two species that occur naturally in the skin: Propionibacterium acnes, which reside in the hair follicles and sebaceous glands of the dermis; and an undisclosed species that lives on the surface. ...